---
figid: PMC9500788__pharmaceutics-14-01760-g005
pmcid: PMC9500788
image_filename: pharmaceutics-14-01760-g005.jpg
figure_link: /pmc/articles/PMC9500788/figure/pharmaceutics-14-01760-f005/
number: Figure 5
figure_title: ''
caption: Schematic diagram of the mechanism of HMON-loaded FTCD nanoparticles in hepatocellular
  carcinoma, by activating mitochondrial apoptosis signaling pathway. Reprinted with
  permission from Ref. []. Copyright 2022 Elsevier Ltd.
article_title: Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer
  in the Era of Precise Medicine.
citation: Han Wu, et al. Pharmaceutics. 2022 Sep;14(9):1760.
year: '2022'

doi: 10.3390/pharmaceutics14091760
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- mesoporous nanoparticles
- liver cancer
- precise medicine
- tumor diagnosis
- nanotechnology

---
